A comparative-effectiveness study that spanned the dominance of SARS-CoV-2 variants of concern finds that the antiviral drug remdesivir significantly reduced in-hospital COVID-19 death rates among adults receiving supplemental oxygen on admission.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
